title: Glucagon injected in the lateral hypothalamus stimulates sympathetic activity and suppresses monoamine metabolism.
abstract: Glucagon injected in the lateral hypothalamus stimulates sympathetic activity and suppresses monamine metabolism. The central hypothesis underlying this study is that there is a reciprocal relationship between food intake and sympathetic activity to IBAT. This hypothesis was tested by using intrahypothalamic microinjections of glucagon, a peptide that has been reported to decrease food intake. Sympathetic nerve activity to interscapular brown adipose tissue (IBAT) was measured as electrophysiological discharges of sympathetic nerves to IBAT. The microinjection of glucagon into the lateral hypothalamus (LH) increased sympathetic nerve activity by +103.8 +/- 35.0% (mean +/- S.E.M.) from pre-injection basal level by 30 min after injection. There was a gradual return to baseline. Micro-injection of glucagon into the LH depressed food intake. Monoamine metabolism was measured by using a microdialysis probe attached to a guide cannula for microinjection of glucagon into the LH. After microinjection of glucagon, the dialysates were collected over 30 min intervals and assayed for norepinephrine (NE), serotonin (5-HT), dopamine (DA) and their metabolites (3-methoxy-4-hydroxyphenylglycol (MHPG); 5-hydroxyindole-3-acetic acid (5-HIAA); and 3,4-dihydroxyphenylacetic acid (DOPAC). Glucagon suppressed both NE and MHPG concentrations in the lateral hypothalamus (LH), and the concentration of DOPAC was also decreased. There was no change of 5-HT concentration but 5-HIAA levels were reduced by glucagon treatment. These data show that glucagon injected in the LH stimulates sympathetic activity and suggest that this may have occurred by suppression of norepinephrine, dopamine and serotonin turnover in the LH of freely moving rats. These data support the hypothesis of a reciprocal relationship between food intake and sympathetic activity.
authors.affiliation: Department of Medicine, University of Southern California, Los Angeles.
authors.forename: H
authors.initials: H
authors.lastname: Shimizu
authors.forename: M
authors.initials: M
authors.lastname: Egawa
authors.forename: H
authors.initials: H
authors.lastname: Yoshimatsu
authors.forename: G A
authors.initials: GA
authors.lastname: Bray
mesh_terms: D002001:Adipose Tissue, Brown / Q000187:drug effects; D000818:Animals; D015306:Biogenic Monoamines / Q000378:metabolism*; D005247:Feeding Behavior / Q000187:drug effects*; D005260:Female; D005934:Glucagon / Q000008:administration & dosage*; D007026:Hypothalamic Area, Lateral / Q000187:drug effects*; D008297:Male; D017551:Microdialysis; D008845:Microinjections; D051381:Rats; D017207:Rats, Sprague-Dawley; D013564:Sympathetic Nervous System / Q000187:drug effects*
chemical_list: D015306:Biogenic Monoamines; D005934:Glucagon